Fintel reports that on October 27, 2026, William Blair downgraded their outlook for Moderna (NASDAQGS:MRNA) (BMV:MRNA) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results